AAV-CRISPR Targets PD-L1 for Ovarian Cancer
In a groundbreaking advancement in ovarian cancer therapeutics, researchers have unveiled a pioneering gene immunotherapy approach leveraging adeno-associated virus (AAV) vectors combined with CRISPR/Cas9 genome...